Objective Platelet antibodies are associated with adverse pregnancy outcomes, such as miscarriage and fetal/neonatal alloimmune thrombocytopenia (FNAIT). However, data on their prevalence and risk factors in the southern Chinese population remain limited. This study aimed to investigate the prevalence of platelet antibodies and their risk factors in pregnant women from southern China, with a particular focus on their association with thyroid diseases.
Methods Blood samples from 5,037 pregnant women presenting for delivery between June 30, 2022, and April 7, 2024, were screened for platelet antibodies via the solid-phase agglutination test. Participants were categorized as platelet antibody positive or negative based on the test results. Clinical data were compared between the two groups. Binary logistic regression analysis was performed to identify independent risk factors for platelet antibody positivity.
Results The overall platelet antibody positivity rate was 7.68%. The positivity increased significantly with both a greater number of pregnancies and a history of miscarriage. Notably, thyroid diseases were strongly associated with platelet antibodies: women with thyroid diseases had a significantly higher positivity rate of 11.55%. Specifically, Hashimoto’s thyroiditis (HT) and thyroid nodules were identified as significant independent risk factors in the binary logistic regression analysis. Other significant independent risk factors included a history of blood transfusion, three or more pregnancies, three or more miscarriages, and thalassemia.
Conclusions This study provides novel evidence of a significant association between maternal thyroid disorders (particularly HT and thyroid nodules) and a higher prevalence of platelet antibodies during pregnancy. These findings highlight the importance of considering thyroid status in antenatal care and suggest a potential benefit of proactive platelet antibody screening, especially in women with thyroid diseases, to help mitigate associated risks such as miscarriage and FNAIT.
| [1] |
Hayashi T, Hirayama F. Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping. Blood Transfus., 2015, 13(3): 380-390
|
| [2] |
Kamphuis MM, Oepkes D. Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenat Diagn., 2011, 31(7): 712-719
|
| [3] |
Kjeldsen-Kragh J, Titze TL, Lie BA, et al. . HLA-DRB3*01: 01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women. Blood Adv., 2019, 3(7): 945-951
|
| [4] |
Nielsen HS, Witvliet MD, Steffensen R, et al. . The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol., 2010, 87(1–2): 67-73
|
| [5] |
Constantinescu S, Zamfirescu V, Vladareanu PR. Fetal and neonatal alloimmune thrombocytopenia. Maedica (Bucur)., 2012, 7(4): 372-376
|
| [6] |
Bonstein L, Haddad N. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia. Thromb Res., 2017, 151(Suppl 1): S100-S102
|
| [7] |
Stam W, Wachholz GE, de Pereda JM, et al. . Fetal and neonatal alloimmune thrombocytopenia: current pathophysiological insights and perspectives for future diagnostics and treatment. Blood Rev., 2023, 59 101038
|
| [8] |
Schmaier AH. Are maternal antiplatelet antibodies a prothrombotic condition leading to miscarriage?. J Clin Invest., 2011, 121(11): 4241-4243
|
| [9] |
Triulzi DJ, Kleinman S, Kakaiya RM, et al. . The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion., 2009, 49(9): 1825-1835
|
| [10] |
Kickler T, Kennedy SD, Braine HG. Alloimmunization to platelet-specific antigens on glycoproteins IIb-IIIa and Ib/IX in multiply transfused thrombocytopenic patients. Transfusion., 1990, 30(7): 622-625
|
| [11] |
Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med., 1997, 337(26): 1861-1869
|
| [12] |
Boelaert K, Newby PR, Simmonds MJ, et al. . Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med., 2010, 123(2): 183.e1-183.e9
|
| [13] |
Klein I, Danzi S. Thyroid disease and the heart. Circulation., 2007, 116(15): 1725-1735
|
| [14] |
Cordiano I, Betterle C, Spadaccino CA, et al. . Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes?. Clin Exp Immunol., 1998, 113(3): 373-378
|
| [15] |
van der Harst D, de Jong D, Limpens J, et al. . Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura. Blood., 1990, 76(11): 2321-2326
|
| [16] |
Wenzek C, Boelen A, Westendorf AM, et al. . The interplay of thyroid hormones and the immune system–where we stand and why we need to know about it. Eur J Endocrinol., 2022, 186(5): R65-R77
|
| [17] |
Jara EL, Muñoz-Durango N, Llanos C, et al. . Modulating the function of the immune system by thyroid hormones and thyrotropin. Immunol Lett., 2017, 184: 76-83
|
| [18] |
Ma C, Wang J, Yang L, et al. . A single-center investigational study of CD36 antigen deficiency and platelet alloantibody distribution in different populations in Northern China as well as platelet alloantibodies effect on pregnancy. Clin Chim Acta., 2019, 498: 68-75
|
| [19] |
Song T, Zhang Y, Huang J, et al. . Transfusion-induced platelet antibodies and regulatory T cells in multiply transfused patients. J Clin Lab Anal., 2021, 35(7): e23864
|
| [20] |
Li C, Piran S, Chen P, et al. . The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. J Clin Invest., 2011, 121(11): 4537-4547
|
| [21] |
Williamson LM, Hackett G, Rennie J, et al. . The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood., 1998, 92(7): 2280-2287
|
| [22] |
Bessos H, Killie MK, Matviyenko M, et al. . Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT). Transfus Apher Sci., 2008, 39(3): 221-227
|
| [23] |
Killie MK, Husebekk A, Kjeldsen-Kragh J, et al. . A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica., 2008, 93(6): 870-877
|
Funding
Guangzhou Municipal Science and Technology Program key projects(202206010795)
RIGHTS & PERMISSIONS
The Author(s), under exclusive licence to the Huazhong University of Science and Technology
PDF
